ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Alloy Therapeutics
This role is a leadership position within Alloy Therapeutics' Genetic Medicines group, focused on developing bioconjugation and delivery technologies for RNA-based therapeutics. The position involves designing and implementing process pipelines for antibody oligonucleotide conjugates and lipid nanoparticles, emphasizing innovation, analytical characterization, and process scale-up.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Alloy Therapeutics is a fully integrated Product Development Organization (PDO) that partners with biotech, pharma, academic, and sovereign organizations to advance drug discovery and development across multiple modalities, including antibodies and multispecifics, TCR mimics, genetic medicines, pharmacology, and cell therapies. The company leverages proprietary AI/ML platforms, real-world data, and tech-enabled services spanning discovery through clinical development to deliver therapeutics with speed and capital efficiency. Alloy also operates specialized subsidiaries, including 82VS for asset-centric venture building and Spannerwerks for early clinical development support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alloy Therapeutics.
Right around the average for this role